Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      • Home
      • Medical Dialogues...

      Articles By : Medical Dialogues Bureau

      China fines pharma firm $1.3 billion in vaccine scandal

      China fines pharma firm $1.3 billion in vaccine scandal

      Medical Dialogues Bureau17 Oct 2018 3:03 PM IST
      BEIJING: Chinese authorities have slapped penalties totaling a whopping US$1.3 billion on a pharmaceutical company over a vaccine scandal that fuelled...
      Johnson & Johnson profit beats, lifts forecast on cancer drug demand

      Johnson & Johnson profit beats, lifts forecast on cancer drug demand

      Medical Dialogues Bureau17 Oct 2018 9:10 AM IST
      Johnson & Johnson reported slightly better-than-expected third quarter profit and raised its full-year forecast on Tuesday as increased demand for...
      CCI Approves Acquisition of Star Health by Jhunjhunwala led Safecrop Holdings

      CCI Approves Acquisition of Star Health by Jhunjhunwala led Safecrop Holdings

      Medical Dialogues Bureau16 Oct 2018 1:57 PM IST
      New Delhi: The Completion Commission said Monday it has approved the acquisition of Star Health and Allied Insurance Company by Safecrop Holdings, a...
      Sanofi, Regeneron say late-stage Dupixent trials show positive results

      Sanofi, Regeneron say late-stage Dupixent trials show positive results

      Medical Dialogues Bureau16 Oct 2018 1:56 PM IST
      PARIS: Drugmakers Sanofi and Regeneron said on Tuesday that they received positive results for their Dupixent product, which treats eczema and is seen...
      Dr Reddys finalises deal to sell Hyderabad API unit to Therapiva

      Dr Reddy's finalises deal to sell Hyderabad API unit to Therapiva

      Medical Dialogues Bureau16 Oct 2018 1:46 PM IST
      New Delhi: Drug major Dr Reddy's Laboratories (DRL) Monday said it will sell its active pharmaceutical ingredient (API) business unit in Hyderabad to...
      Novo Nordisk picks AstraZeneca executive to head biopharma business

      Novo Nordisk picks AstraZeneca executive to head biopharma business

      Medical Dialogues Bureau16 Oct 2018 9:00 AM IST
      COPENHAGEN: Novo Nordisk has hired AstraZeneca's head of cardiovascular and metabolic diseases to head its biopharma business, which has been...
      Looking to establish presence in China: Lupin

      Looking to establish presence in China: Lupin

      Medical Dialogues Bureau15 Oct 2018 2:07 PM IST
      Mumbai: Drug major Lupin is looking to establish presence in China as part of its strategy to strengthen its markets in the Asia Pacific region, a...
      Dr Reddys Laboratories recalls 35,000 tubes of skin infection cream from US

      Dr Reddy's Laboratories recalls 35,000 tubes of skin infection cream from US

      Medical Dialogues Bureau15 Oct 2018 2:05 PM IST
      New Delhi: Dr Reddy's Laboratories' US arm is recalling over 35,000 tubes of Nystatin and Triamcinolone Acetonide cream on account of failed...
      Sun Pharma to Pump in Rs 200 Crore More in Assam Plant

      Sun Pharma to Pump in Rs 200 Crore More in Assam Plant

      Medical Dialogues Bureau15 Oct 2018 2:01 PM IST
      Guwahati: Assam government on Saturday said medicine firm Sun Pharma will invest an additional Rs 200 crore at its plant in the state to augment...
      Diagnostic startup Healthians launches operations in Punjab

      Diagnostic startup Healthians launches operations in Punjab

      Medical Dialogues Bureau15 Oct 2018 9:56 AM IST
      Chandigarh: Online diagnostic startup Healthians Friday announced the launch of its operations in Punjab. Healthians will be making an investment of...
      Embattled Chinese drug maker to get 43 million dollars in government support

      Embattled Chinese drug maker to get 43 million dollars in government support

      Medical Dialogues Bureau15 Oct 2018 9:04 AM IST
      SHANGHAI: - A Chinese city government has given 300 million yuan ($43 million) to drug maker Zhejiang Huahai Pharmaceuticals, the company said, after...
      Eli Lilly Launches Olumiant-once-daily oral therapy for rheumatoid arthritis In India

      Eli Lilly Launches Olumiant-once-daily oral therapy for rheumatoid arthritis In India

      Medical Dialogues Bureau14 Oct 2018 11:33 AM IST
      Rheumatoid Arthritis is a systemic autoimmune disease characterized by inflammation and progressive destruction of jointsNew Delhi: Drug firm Eli...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok